Back

FABP4 Couples Lipid Metabolism to PD-L1 Stabilization in Immunosuppressive Macrophages

Yu, J.; Shilyansky, J.; Avellino, A.; Hao, J.; Sun, Y.; Jiang, X.; Wang, Z.; Han, X.; Curry, M. A.; Sugg, S.; Li, B.

2026-04-13 immunology
10.64898/2026.04.09.717546 bioRxiv
Show abstract

Metabolic dysregulation in obesity reshapes immune function, but how lipid signals drive immune suppression remains unclear. Here, we identify a FABP4-PD-L1 axis that links lipid metabolism to immune checkpoint regulation in monocytes and macrophages. Single-cell transcriptomics revealed a distinct FABP4high immunosuppressive macrophage subset enriched under high-fat diet (HFD) conditions, characterized by impaired antigen presentation and elevated PD-L1 expression. Mechanistically, palmitic acid (PA) induces FABP4 and promotes PD-L1 palmitoylation, leading to its stabilization on the cell surface independent of transcriptional regulation. FABP4 is essential for this process, which enables PD-L1 surface stabilization, immunosuppression and mammary tumor progression. In humans, a conserved CD14intCD16 monocyte population exhibits elevated FABP4-PD-L1 signaling and correlates with obesity and invasive breast cancer. These findings establish PD-L1 as a metabolically regulated protein and reveal a mechanism by which lipid excess drives immune evasion, suggesting that targeting FABP4 may enhance responses to immune checkpoint blockade. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/717546v1_ufig1.gif" ALT="Figure 1"> View larger version (50K): org.highwire.dtl.DTLVardef@1cce278org.highwire.dtl.DTLVardef@2848b1org.highwire.dtl.DTLVardef@bc9c25org.highwire.dtl.DTLVardef@af5e3c_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIFABP4 defines a lipid-responsive, immunosuppressive monocyte/macrophage subset C_LIO_LIFABP4 links lipid sensing to PD-L1 expression in macrophages C_LIO_LIFABP4 enables palmitic acid-dependent PD-L1 palmitoylation and stabilization C_LIO_LIFABP4-PD-L1 signaling correlates with obesity and invasive breast cancer in humans C_LI

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Cell Reports
1338 papers in training set
Top 0.3%
18.5%
2
Nature Metabolism
56 papers in training set
Top 0.1%
10.0%
3
Nature
575 papers in training set
Top 3%
10.0%
4
Immunity
58 papers in training set
Top 0.8%
6.3%
5
Cell
370 papers in training set
Top 3%
6.3%
50% of probability mass above
6
Nature Communications
4913 papers in training set
Top 33%
4.8%
7
Nature Immunology
71 papers in training set
Top 0.6%
3.6%
8
eLife
5422 papers in training set
Top 29%
3.2%
9
Science
429 papers in training set
Top 11%
2.7%
10
Molecular Cell
308 papers in training set
Top 5%
2.7%
11
Journal of Experimental Medicine
106 papers in training set
Top 1%
2.4%
12
Cell Systems
167 papers in training set
Top 6%
2.1%
13
Science Advances
1098 papers in training set
Top 13%
2.1%
14
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.1%
15
Cell Metabolism
49 papers in training set
Top 0.9%
1.9%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 32%
1.7%
17
The EMBO Journal
267 papers in training set
Top 4%
0.9%
18
Cell Host & Microbe
113 papers in training set
Top 4%
0.9%
19
Cancer Discovery
61 papers in training set
Top 2%
0.8%
20
Cell Chemical Biology
81 papers in training set
Top 3%
0.8%
21
Journal of Cell Biology
333 papers in training set
Top 4%
0.8%
22
Nature Cell Biology
99 papers in training set
Top 4%
0.7%
23
Cell Genomics
162 papers in training set
Top 7%
0.7%
24
EMBO reports
136 papers in training set
Top 8%
0.6%